Quarterly report · Q1
7745.TEDINET S100RNZL
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.4bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥59.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.0bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥1.1bn | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | −¥219m | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.3bn | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥7.6bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1m | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.3bn | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥6m | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥836m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.5bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥159m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥839m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | −¥153m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥68.9bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥69.4bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥64.5bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥35.6bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥36.8bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥33.3bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥32.6bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥31.1bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥14.9bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥30.47 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥201.33 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.83 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥30.44 | 2023-04-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥201.14 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 48.2% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.9% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 98
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥5.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥5.5bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | −¥586m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥1.1bn |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥52m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥63m |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥2.3bn |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥2.3bn |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥138m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥1.8bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥668m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥102m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥85m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥1.9bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥97m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥149m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥148m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | −¥11m |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥2m |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥128m |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥3.8bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥3.2bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥650m |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | −¥209m |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥3.4bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥2.2bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥436m |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥2.7bn |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥2.7bn |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥941m |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥7.0bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥5.6bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | −¥55m |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥9.2bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥5.1bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥4.2bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥800m |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥2.7bn |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥2.7bn |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥941m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥6.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥6.9bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥1.6bn |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥18m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥102m |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | −¥116m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.1bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥917m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥175m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.5bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥132m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2.3bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥124m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥231m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥230m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥10m |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥131m |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥4.1bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥3.1bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | −¥15m |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥4.1bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2.6bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥652m |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥322m |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥7.6bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥5.7bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥272m |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥10.1bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥5.1bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥792m |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥322m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 442
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -586000000 | JPY |
| Operating income | CurrentYTDDuration | 1099000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-08-10 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第47期第１四半期(自 2023年４月１日 至 2023年６月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社Ａ＆Ｄホロンホールディングス | |
| Company name in english cover page | FilingDateInstant | A&D HOLON Holdings Company, Limited | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役執行役員社長 森 島 泰 信 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都豊島区東池袋三丁目23番14号(同所は登記上の本店所在地で実際の業務は「最寄りの連絡場所」で行っております。) | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)該当事項はありません。 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)該当事項はありません。 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)埼玉県北本市朝日一丁目243番地 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)(０４８) ５９３－１５９０ (代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役上席執行役員 高 橋 浩 二 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E02344 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 77450 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社Ａ＆Ｄホロンホールディングス | |
| Filer name in english | FilingDateInstant | A&D HOLON Holdings Company, Limited | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2023-04-01 | |
| Current period end date | FilingDateInstant | 2023-06-30 | |
| Type of current period | FilingDateInstant | Q1 | |
| Current fiscal year end date | FilingDateInstant | 2024-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Comparative period end date | FilingDateInstant | 2022-06-30 | |
| Previous fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |